PDT Partners LLC Invests $856,000 in Cross Country Healthcare, Inc. (NASDAQ:CCRN)

PDT Partners LLC bought a new stake in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 63,657 shares of the business services provider's stock, valued at approximately $856,000. PDT Partners LLC owned about 0.19% of Cross Country Healthcare as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Truvestments Capital LLC purchased a new stake in Cross Country Healthcare during the 3rd quarter worth approximately $39,000. nVerses Capital LLC purchased a new position in Cross Country Healthcare in the second quarter valued at $50,000. Gladius Capital Management LP grew its stake in Cross Country Healthcare by 83.4% during the 3rd quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider's stock worth $54,000 after purchasing an additional 1,812 shares in the last quarter. US Bancorp DE increased its holdings in Cross Country Healthcare by 10,909.3% during the 3rd quarter. US Bancorp DE now owns 4,734 shares of the business services provider's stock worth $64,000 after purchasing an additional 4,691 shares during the period. Finally, GAMMA Investing LLC raised its position in Cross Country Healthcare by 622.4% in the 2nd quarter. GAMMA Investing LLC now owns 5,678 shares of the business services provider's stock valued at $79,000 after purchasing an additional 4,892 shares in the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CCRN has been the topic of several recent analyst reports. Benchmark dropped their target price on Cross Country Healthcare from $19.00 to $18.00 and set a "buy" rating on the stock in a report on Thursday, November 7th. Truist Financial cut their target price on Cross Country Healthcare from $17.00 to $15.00 and set a "hold" rating on the stock in a research report on Monday, October 21st. Finally, Barrington Research decreased their target price on Cross Country Healthcare from $21.00 to $19.00 and set an "outperform" rating for the company in a research note on Thursday, August 8th. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $17.33.

Cross Country Healthcare Stock Performance

Shares of CCRN stock traded down $0.36 during mid-day trading on Tuesday, hitting $11.16. 339,338 shares of the stock were exchanged, compared to its average volume of 570,034. The stock's fifty day simple moving average is $11.69 and its two-hundred day simple moving average is $13.63. Cross Country Healthcare, Inc. has a 12-month low of $9.58 and a 12-month high of $23.64. The stock has a market capitalization of $367.39 million, a price-to-earnings ratio of -223.16, a P/E/G ratio of 2.20 and a beta of 0.61.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.